+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rizatriptan"

From
Acute Migraine Treatment Market Report 2025 - Product Thumbnail Image

Acute Migraine Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Migraine Drugs Market Report 2025 - Product Thumbnail Image

Migraine Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Migraine - Pipeline Insight, 2025 - Product Thumbnail Image

Migraine - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Rizatriptan is a medication used to treat migraine headaches. It belongs to a class of drugs known as triptans, which are used to treat moderate to severe migraine pain. Rizatriptan works by narrowing the blood vessels around the brain, reducing inflammation and relieving pain. It is available in both oral and nasal spray forms. Rizatriptan is part of the Central Nervous System (CNS) drug market, which includes medications used to treat a variety of neurological conditions. These drugs are used to treat conditions such as depression, anxiety, epilepsy, and Parkinson's disease. The CNS drug market is highly competitive, with many different companies offering a variety of medications. Some of the companies in the Rizatriptan market include Merck & Co., Inc., GlaxoSmithKline, Pfizer, Inc., and Teva Pharmaceuticals. Show Less Read more